Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya
Vincent Ochieng-Ooko, Daniel Ochieng, John E Sidle, Margaret Holdsworth, Kara Wools-Kaloustian, Abraham M Siika, Constantin T Yiannoutsos, Michael Owiti, Sylvester Kimaiyo & Paula Braitstein
Volume 88, Number 9, September 2010, 681-688
Table 1. Clinical and sociodemographic characteristics of patients enrolled at clinics for the treatment of HIV infection, by gender, Kenya, 2001–2007
| Patient’s characteristic | Women (n = 34 606) |
Men (n = 15 669) |
P-value |
|---|---|---|---|
| Attended at least one follow-up visit, no. (%) | 31 959 (92) | 14 266 (91) | < 0.001 |
| Age in years, median (IQR) | 35 (29–42) | 40 (34–47) | < 0.001 |
| Patient disclosed HIV+ status,a no. (%) | 19 259 (61) | 9 429 (67) | < 0.001 |
| Attended an urban clinic, no. (%) | 17 061 (49) | 8 171 (52) | < 0.001 |
| WHO stage-III/IV HIV disease,b no. (%) | 10 842 (38) | 6 730 (53) | < 0.001 |
| CD4+ lymphocyte countc in cells/µl, median (IQR) | 225 (98–408) | 154 (57–302) | < 0.001 |
| Travel time to the clinic ≥ 1 hour,d no. (%) | 13 166 (41) | 5 989 (41) | 0.54 |
| Previously received cART, no. (%) | 19 550 (56) | 8 916 (57) | 0.39 |
| Year of enrolment | 0.22 | ||
| 2001–2004, no. (%) | 4 695 (14) | 2 089 (13) | – |
| 2005–2006, no. (%) | 18 797 (54) | 8 426 (54) | – |
| 2007, no. (%) | 11 114 (32) | 5 154 (33) | – |
cART, combination antiretroviral therapy; HIV, human immunodeficiency virus; IQR, interquartile range; WHO, World Health Organization.
a Data on disclosure were missing for 3306 women (9.6%) and 1514 men (9.7%).
b Data on disease stage were missing for 6253 women (18.1%) and 3024 men (19.3%).
c Data on lymphocyte count were missing for 5464 women (15.8%) and 2604 men (16.6%).
d Data on travel times were missing for 2441 women (7.1%) and 1146 men (7.3%).